Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Oligobs PMS
- Development stage
- Unknown
- Lead developer
- Laboratoire CCD
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Oligobs PMS (also known as Oligobs SPM/PMS or Oligobs 28) is an approved food supplement developed by Laboratoire CCD, a French pharmaceutical laboratory specializing in women's health. It is indicated for the relief of premenstrual syndrome (PMS) symptoms and is designed to promote premenstrual comfort and well-being. The product is formulated with a synergistic blend of active ingredients, including saffron extract (to support emotional balance, relaxation, and positive mood), butcher's-broom (Petit Houx) extract (to support venous circulation and reduce bloating or swelling), magnesium and vitamin B6 (to contribute to normal psychological function, reduce fatigue, and regulate hormonal activity), and zinc (to support cognitive function). Oligobs PMS is administered orally as tablets, typically taken for 10 days preceding menstruation.
- Brand names
- Oligobs 28Oligobs28Oligobs-28Oligobs PMSOligobs SPMOligobs SPM/PMS
- Other names
- Oligobs Confort PrémenstruelOligobs SPM/PMS Confort Prémenstruel
Beyond the preview
Go deeper on Oligobs PMS.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Oligobs PMS.